Medincell (XPAR:MEDCL) Price-to-Operating-Cash-Flow : (As of May. 31, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Medincell Price-to-Operating-Cash-Flow?

As of today (2024-05-31), Medincell's share price is €16.36. Medincell's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.86. Hence, Medincell's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Medincell's Price-to-Operating-Cash-Flow or its related term are showing as below:

XPAR:MEDCL's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.32
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Medincell's Cash Flow from Operations per share for the six months ended in Sep. 2023 was €-0.42. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.86.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -10.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -11.00% per year.

During the past 8 years, Medincell's highest 3-Year average Operating Cash Flow per Share Growth Rate was 2.40% per year. The lowest was -38.50% per year. And the median was -11.85% per year.

Medincell Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Medincell's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medincell Price-to-Operating-Cash-Flow Chart

Medincell Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Medincell Semi-Annual Data
	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Medincell's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Medincell's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medincell's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medincell's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medincell's Price-to-Operating-Cash-Flow falls into.

Medincell Price-to-Operating-Cash-Flow Calculation

Medincell's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	16.36	/	-0.86
	=

Medincell's Share Price of today is €16.36.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medincell's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.86.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Medincell Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medincell's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Medincell (XPAR:MEDCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medincell SA (XPAR:MEDCL) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

MEB:Germany

Address

3 rue des Freres Lumiere, Jacou, FRA, 34830

Website

https://www.medincell.com

Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.

Medincell (XPAR:MEDCL) Headlines

No Headlines